Daily BriefsUnited States

Daily Brief United States: O2Micro International, Match Group Inc, Lam Research, Servicenow Inc, International Business Machines, Pfizer Inc, Freeport Mcmoran, Procter & Gamble Co, Hesai Group, Boeing Co and more

In today’s briefing:

  • O2Micro (OIIM US): US$5 Privatisation Approved, Spread Remains Wide
  • MTCH 4Q22: More Bullish Than You Think
  • Lam Research Corp: Acquisition Of Semsysco GmbH & Other Drivers
  • ServiceNow Inc: New Offerings & Other Drivers
  • International Business Machines (IBM): New Analytics Offerings & Other Drivers
  • Pfizer Inc (PFE US): Q4 Result- In-Line Revenue & EPS Ahead of Guidance; Initiates 2023 Guidance
  • Freeport-McMoRan: Major Drivers
  • Procter & Gamble: Recent Earnings Reaffirm My Cautious View On The Stock
  • Hesai Group Pre-IPO –  Peer Comparison – Not Really the Largest, Globally or Locally
  • Boeing Co: New Military Aircraft Launch & Other Developments

O2Micro (OIIM US): US$5 Privatisation Approved, Spread Remains Wide

By Arun George

  • O2Micro International (OIIM US)‘s US$5.00 per ADS privatisation offer from FNOF Precious Honour Limited was overwhelmingly approved by shareholders.
  • The key remaining condition precedent is obtaining the required regulatory approvals related to the listing rules of NASDAQ and the Cayman Islands. There are no Chinese regulatory approvals required.
  • The conditions precedent should be satisfied shortly. At the current price and for an end-March close, the gross and annualised spread to the offer is 6.4% and 45.6%, respectively. 

MTCH 4Q22: More Bullish Than You Think

By Aaron Gabin

  • Inline performance and inline guidance…the stock mistakingly traded down on Tinder’s optically weak sub growth.
  • Longer term, CEO BK Kim is making the right moves reorganizing the company to focus on the growth engines (Tinder, Hinge), the idiosyncrantic drivers (Asia), and cost cutting (Evergreen Brands).
  • Reiterated 2023 guidance will prove conservative, with the stock still trading at alltime lows despite the 30% move up so far this year…we buy this dip.

Lam Research Corp: Acquisition Of Semsysco GmbH & Other Drivers

By Baptista Research

  • Lam Research ended the previous year on a strong note and posted an all-around beat in the last quarter.
  • The CSBG revenues in the company’s installed base business expanded faster than its growth in the installed base units.
  • We provide the stock of Lam Research with an ‘Underperform’ rating with a revision in the target price.

ServiceNow Inc: New Offerings & Other Drivers

By Baptista Research

  • ServiceNow continues performing well as its recent quarterly result met market expectations in terms of the reported revenues.
  • The company exceeded its subscription revenue guidance and drove strong expansion and renewal rates.
  • The free cash flow was above its guidance, and it beat the guidance with the growth in subscription revenue and also managed an earnings beat.

International Business Machines (IBM): New Analytics Offerings & Other Drivers

By Baptista Research

  • IBM delivered a strong result for the last quarter and managed an all-around beat as a result of excellent execution with respect to its AI and hybrid cloud strategy.
  • It delivered decent revenue growth in its business across geographies, infrastructure segments, consulting, and software.
  • The company added a series of innovative IBM software offerings in the AWS marketplace available as-a-Service.

Pfizer Inc (PFE US): Q4 Result- In-Line Revenue & EPS Ahead of Guidance; Initiates 2023 Guidance

By Tina Banerjee

  • Pfizer Inc (PFE US) reported 13% operational revenue growth in Q4, driven by strong performance of the COVID products and ongoing launch of Prevnar 20 for adults in U.S.
  • Pfizer has provided full-year 2023 revenue guidance of $67.0–71.0B (-31% YoY at mid-point) and adjusted EPS guidance of $3.25–3.45 (-49% YoY at mid-point).
  • The company is in the midst of an 18-month period during which Pfizer expects to have up to an unprecedented 19 new products or indications in the market.

Freeport-McMoRan: Major Drivers

By Baptista Research

  • This was a strong quarter for Freeport with the company managing an all-around beat.
  • Indonesia’s operations by PT Freeport Indonesia are characterized by very low costs due to the gold content and the grades, large volumes, and the world’s largest goldmine is a byproduct.
  • In the quarter, gold and copper sales exceeded the guidance of the company and the company generated strong margins.

Procter & Gamble: Recent Earnings Reaffirm My Cautious View On The Stock

By Vladimir Dimitrov, CFA

  • Procter & Gamble’s share price appears to be running ahead of business fundamentals.
  • P&G has a limited upside over the short to medium term, according to the recent earnings report.
  • The company has a free cash flow point of view, but has a limited upside over a short-term term.

Hesai Group Pre-IPO –  Peer Comparison – Not Really the Largest, Globally or Locally

By Sumeet Singh

  • Hesai Group (HSAI US) is looking to raise at least US$100m in its upcoming US IPO.
  • HSAI is a manufacturer of three-dimensional light detection and ranging (Lidar) solutions. It has shipped over 103,000 Lidar units from 2017 to the end of 2022.
  • In this note, we will undertake a peer comparison with domestic and US-listed peers.

Boeing Co: New Military Aircraft Launch & Other Developments

By Baptista Research

  • Boeing had another weak quarter and failed to meet Wall Street expectations with respect to revenues as well as earnings.
  • The company managed over $3 billion in free cash flow driven by the progress in its performance and continued demand.
  • Boeing has a strong pipeline of development programs, and it has been preparing itself for the next generation of products.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars